An article entitled "Clinical and CSF single-cell
Post# of 145338
![](/assets/46931549/no_avatar_available_thumb.jpg)
Highlights:
• Improvement from post-COVID-19 cognitive impairment (CI) is slow
• Post-COVID-19 CI is molecularly distinct from Alzheimer’s disease
• Post-COVID-19 CI is associated with CSF monocyte recruitment and gene alterations
• Improvement from post-COVID-19 CI is linked to greater CSF interferon responses
https://www.cell.com/cell-reports-medicine/fu...24)00253-2
Very technical and lengthy article.
ohm, if you see anything relevant re Leronlimab, please let us know.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)